Third generation oral contraceptive use and cardiovascular risk factors

This publication has 23 references indexed in Scilit:

• Increased Levels of C-Reactive Protein After Oral Hormone Replacement Therapy May Not Be Related to an Increased Inflammatory Response
  Circulation, 2003
• Measurement of plasma viscosity in stored frozen samples
  Blood Coagulation & Fibrinolysis, 2003
• Effect of Transdermal Estradiol and Oral Conjugated Estrogen on C-Reactive Protein in Retinoid-Placebo Trial in Healthy Women
  Circulation, 2002
• Oral Contraceptives and the Risk of Myocardial Infarction
  New England Journal of Medicine, 2001
• Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
  BMJ, 2001
• Hormone Replacement Therapy and Increased Plasma Concentration of C-Reactive Protein
  Circulation, 1999
• Oral contraceptives and myocardial infarction: results of the MICA case-control study Commentary: Oral contraceptives and myocardial infarction: reassuring new findings
  BMJ, 1999
• Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
  JAMA, 1998
• Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study
  The Lancet, 1997
• PULMONARY EMBOLISM
  The Lancet, 1961